hotspot -WSS

hotspot

author：knowledge 2025-10-01 18:23:19 - browse：31229

Electrocardiogram in the shape of the United States map — Adobe

The market for artificial intelligence in health care is about as transparent as a brick wall. New tools achieve impressive results in published studies. But it is often difficult to compare them head to head with similar products, or tell whether they will work on different kinds of patients.

A new company is promising to change that — if it can convince AI developers to expose their products to more rigorous testing.

Called Dandelion Health, the New York-based firm is launching a first-of-its-kind public service to evaluate AI products on independent data designed to root out weaknesses and reveal bias. The company said Wednesday its initial pilot program, to begin next month, will focus on testing algorithms that use electrocardiograms to predict heart conditions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Skip the lead apron during X

WSS

The biotech scorecard for Q3: 15 stock

A letter from the executive editor: The 2023 STATUS List

Use doctors trained outside the U.S. to ease the physician shortage

Being 'nonadherent' patient made me a more empathetic doctor

Vertex cell therapy lets patients with type 1 diabetes stop insulin

The wait for US passports is creating travel purgatory and snarling summer plans

explore

hotspot

focus

Jerome Adams on the need for new antivirals for Covid

What affirmative action's end means to a medical student

Supreme Court strikes down use of affirmative action

Undocumented workers face uncertainty as immigration law takes effect in Florida

Psychedelics group wrestles with new pharma identity

The biotech scorecard for Q3: 15 stock

Affirmative action in medical school literally saved lives

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

State Dept. review finds Biden bears some blame for Afghanistan failures

Vertex cell therapy lets patients with type 1 diabetes stop insulin

focus

Hubble vs. James Webb telescope images: See the difference

Dexcom's push to bring CGM to type 2 diabetes patients

Lupron, used to halt puberty in children, may cause lasting health problems

The wait for US passports is creating travel purgatory and snarling summer plans

Dexcom's push to bring CGM to type 2 diabetes patients

The biotech scorecard for Q3: 15 stock

Wikipedia

hotspot

Wikipedia

leisure time